Nervous System Cancer: December 2006 Archives

Genetic test checks aggressivity of nervous system cancer

nervous system cancerHeidelberg - A new genetic test helps doctors better predict the progression of neuroblastoma in children, the German Cancer Research Centre in Heidelberg said. Neuroblastoma is the most common solid cancer in infancy and childhood outside the head and brain. Of 100,000 children up to age 14 between one and three die of neurobastoma.

The type of cancer, which is marked by malignant growths in the nervous system, progresses in different ways. In 10 per cent of the cases, tumours shrink even after metasteses have begun forming. In other cases the patients die despite intensive treatment.

Researchers at the German Cancer Research Centre and the University of Cologne have developed a method based on the genetic activity of the tumour cells that rates the aggressiveness of the neuroblastoma at the time of diagnosis.

About this Archive

This page is a archive of entries in the Nervous System Cancer category from December 2006.

Find recent content on the main index or look in the archives to find all content.